Annual Drug Patent Expirations for ADVAIR+HFA Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from three suppliers. There are…
The post New patent expiration for Glaxo Grp drug ADVAIR HFA appeared first on Dru…
New patent expiration for Glaxo Grp drug ADVAIR HFA Read Post »
Annual Drug Patent Expirations for VENTOLIN+HFA Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from nine suppliers. There are two patents…
The post New patent expiration for Glaxosmithkline drug VENTOLIN …
New patent expiration for Glaxosmithkline drug VENTOLIN HFA Read Post »
Annual Drug Patent Expirations for FLOVENT+HFA Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from five suppliers. There are…
The post New patent expiration for Glaxo Grp drug FLOVENT HFA appeared first on D…
New patent expiration for Glaxo Grp drug FLOVENT HFA Read Post »
Annual Drug Patent Expirations for VYNDAMAX Vyndamax is a drug marketed by Foldrx Pharms and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Foldrx Pharms drug VYNDAMAX appeared fir…
New patent expiration for Foldrx Pharms drug VYNDAMAX Read Post »
Annual Drug Patent Expirations for VYNDAQEL Vyndaqel is a drug marketed by Foldrx Pharms and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Foldrx Pharms drug VYNDAQEL appeared firs…
New patent expiration for Foldrx Pharms drug VYNDAQEL Read Post »
VENTOLIN HFA (albuterol sulfate) Glaxosmithkline Patent: 7,832,351 Expiration: Dec 19, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The pos…
Drug Patent Expirations for the Week of December 17, 2023 Read Post »
VENTOLIN HFA (albuterol sulfate) Glaxosmithkline Patent: 7,832,351 Expiration: Dec 19, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The pos…
Drug Patent Expirations for the Week of December 17, 2023 Read Post »
Annual Drug Patent Expirations for RAPIVAB Rapivab is a drug marketed by Biocryst and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Biocryst drug RAPIVAB appeared first…
Annual Drug Patent Expirations for PRADAXA Pradaxa is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from four suppliers. There are four patents…
The post New patent expiration for Boehringer Ingelheim drug PRADAXA…
New patent expiration for Boehringer Ingelheim drug PRADAXA Read Post »
Annual Drug Patent Expirations for DYMISTA Dymista is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from two suppliers. There are four…
The post New patent expiration for Mylan Speciality drug DYMISTA appeared first…
New patent expiration for Mylan Speciality drug DYMISTA Read Post »